ZYXI Stock: Zynex, Inc. Stock Price, Analysis & Insights
Get live zyxi stock price $1.06, comprehensive Zynex, Inc. stock analysis, charts, news, and expert forecast. Real-time zyxi stock data and investment insights.
Loading chart...
Company Overview
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Company Information
- CEO
- Steven Lewis Dyson
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 1000
Contact Information
- Website
- https://www.zynex.com
- Address
- 9655 Maroon Circle
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Zynex, Inc. operates in the Medical - Distribution industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Steven Lewis Dyson, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Distribution model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Zynex, Inc. competes in the Medical - Distribution within the broader Healthcare. With 32.2 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Zynex, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Zynex, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Zynex, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Zynex, Inc.
- ⚠Investors should consider how Zynex, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
32.17M
P/E Ratio
-0.44
Beta
1.01
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 32.17M market capitalization
- Trading Volume: 11.44M shares traded today
- Price Range: 52-week range of $0.38 - $8.72
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Zynex, Inc.
Zynex, Inc. (ZYXI) operates in the Medical - Distribution industry within the Healthcare sector. With a current market capitalization of 32.17M, the company represents a significant player in its market. The stock is currently trading at $1.06 with a positivedaily change of 43.54%.
The company's 1000 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.44, beta of 1.01, and 52-week price range from $0.38 to $8.72when evaluating investment opportunities.
Why Invest in Zynex, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Steven Lewis Dyson
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.